Tag: licensing
-

Trial Shows Nanotech Drug Induces Gluten Tolerance
Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease.
-

High-Speed Industrial 3-D Printing Demonstrated
An engineering team developed a high-speed three-dimensional printing process that can produce large, detailed items of various materials on demand.
-

Merck Gaining Gut Microbe Technology for Vaccines
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines.
-

Biotech Developing Genome-Adjusting Disease Treatments
A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins.
-

Start-Up Targets Extra DNA in Cancer, Raises $46.4M
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes.
-

Gel, Crispr Help Defeat Cancer Drug Obstacles
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells.
-

NIH Funds Augmented-Reality Endovascular System
A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels.
-

Hydrogel Shown Safe to Repair Heart Damage
Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients.
-

Gene-Editing Biotech Gains $34M in Early Funds
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles.
-

Spin-Off Licensing Athletic Microbiome Technology
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics.